Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - albutrepenonacog alfa -

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - albutrepenonacog alfa -

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - albutrepenonacog alfa -

Israël - anglais - Ministry of Health

csl behring ltd., israel - albutrepenonacog alfa - powder and solvent for solution for injection - albutrepenonacog alfa 250 iu - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Singapour - anglais - HSA (Health Sciences Authority)

csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 1000iu/vial

Singapour - anglais - HSA (Health Sciences Authority)

csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 2000iu/vial

Singapour - anglais - HSA (Health Sciences Authority)

csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 250iu/vial

Singapour - anglais - HSA (Health Sciences Authority)

csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 500iu/vial

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 1000 [iu];  ;   - powder for injection - 1000 iu - active: albutrepenonacog alfa 1000 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 2000 [iu];  ;   - powder for injection - 2000 iu - active: albutrepenonacog alfa 2000 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.